Based on the most helpful WSO content, some top-tier early-stage biotech venture capital firms that are known for leading Series A deals and might be interested in first-in-class early stage oncology assets include:

  • Atlas Venture
  • Third Rock
  • 5AM Ventures
  • Flagship Pioneering
  • Orbimed
  • Versant Ventures
  • ARCH Venture Partners

These firms are akin to the MBB (McKinsey, Bain, BCG) or bulge bracket banks of the biotech VC world, often leading the pack in terms of investment in innovative and groundbreaking biotech startups. They are known for their deep scientific expertise and may be more inclined to invest in cutting-edge oncology research rather than more conservative medtech ventures.

Sources: Healthcare / Biotech Venture Capital?, Biotech finance: from IB to VC / HF to funded startup, Guide To Evaluate a Biotech Company, Guide To Evaluate a Biotech Company

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 

Amet nobis unde enim qui molestiae exercitationem recusandae doloribus. Temporibus enim molestiae omnis sit aperiam. Reiciendis natus vel labore sunt. Ut odio incidunt est nostrum quasi voluptatem.

Vel exercitationem eos sit quae reprehenderit. Mollitia et officia harum est eveniet aperiam. Omnis reprehenderit corporis perspiciatis blanditiis. Dolor rerum quae omnis soluta nihil error. Esse ab reiciendis odio ut ut. Et neque iusto voluptas eos voluptates neque.

Minima corrupti nesciunt id vitae repudiandae. Iusto qui est repellat quo. Expedita in repellat aliquid. Enim aut omnis magnam corporis harum totam nihil. Atque voluptatem perspiciatis non et. Commodi ut corrupti vitae pariatur consequatur. Veritatis facilis ipsam eveniet enim consequatur magni.

Quis rerum accusamus et omnis. Facere dolores deserunt ducimus quisquam sed commodi est. Rerum voluptas esse doloremque quibusdam. Sint quia dignissimos quia voluptate. Et distinctio praesentium labore ad vero fuga ipsum quia.

Career Advancement Opportunities

May 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Lazard Freres No 98.8%
  • Harris Williams & Co. 25 98.3%
  • Goldman Sachs 17 97.7%
  • JPMorgan Chase 04 97.1%

Overall Employee Satisfaction

May 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

May 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

May 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (21) $373
  • Associates (91) $259
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (68) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
Secyh62's picture
Secyh62
99.0
5
dosk17's picture
dosk17
98.9
6
GameTheory's picture
GameTheory
98.9
7
kanon's picture
kanon
98.9
8
CompBanker's picture
CompBanker
98.9
9
numi's picture
numi
98.8
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”